, Volume 174, Issue 3, pp 367–375 | Cite as

Rewarding effects elicited by cocaine microinjections into the ventral tegmental area of C57BL/6 mice: involvement of dopamine D1 and serotonin1B receptors

  • Vincent David
  • Louis Segu
  • Marie-Christine Buhot
  • Marina Ichaye
  • Pierre Cazala
Original Investigation



The role of ventral tegmental area (VTA) in mediating the rewarding effects of cocaine has not been extensively studied.


We used the intracranial self-administration (ICSA) procedure to assess the involvement of the VTA in the rewarding effects of cocaine, and the effect of dopamine (DA) D1- and serotonin (5-HT)1B-receptor antagonists on ICSA of cocaine.


Adult male C57BL/6 mice were stereotaxically implanted, unilaterally, with a guide cannula either 1.5 or 2.3 mm above the VTA. After 1 week, mice were trained to discriminate between the two arms of a Y-maze over seven daily sessions, one arm being reinforced by intracranial cocaine microinjections. Starting from session 8, the D1 and 5-HT1B-receptor antagonists were injected IP pre-test each day over five consecutive sessions.


Mice injected into the VTA rapidly exhibited a preference for the cocaine-reinforced arm, whatever the dose of cocaine available (30 pmol or 150 pmol per injection), reaching optimum ICSA performance within 5 days. In contrast, mice injected 0.8 mm above the VTA did not discriminate between the arms of the maze and performed at random, except for one subject. Once the ICSA response was acquired, systemic pre-injections of either the D1 (SCH23390; 25 μg/kg IP) or 5-HT1B (GR127935; 0.5 mg/kg IP) antagonist disrupted this behavior. Replacement of each antagonist by vehicle led to the reinstatement of intra-VTA cocaine self-administration.


The results of the present study suggest that VTA neurons play a critical role in mediating the rewarding effects of acute cocaine and that both D1 and 5-HT1B receptors modulate these effects.


Ventral tegmental area Intracranial self-administration Cocaine reinforcement 5-HT receptors Dopamine D receptors GR127935 SCH23390 



We would like to thank Mrs. L. Decorte and D. Panzeri for their excellent technical assistance and Dr. T.P. Durkin for correction of the English text and useful discussions. This investigation was supported by the CNRS (UMR 5106).


  1. Belzung C, Scearce-Levie K, Barreau S, Hen R (2000) Absence of cocaine-induced place conditioning in serotonin 1B receptor knock-out mice. Pharmacol Biochem Behav 66:221–225PubMedGoogle Scholar
  2. Bhat RV, Baraban JM (1993) Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J Pharmacol Exp Ther 267:496–505PubMedGoogle Scholar
  3. Boulenguez P, Rawlins JN, Chauveau J, Joseph MH, Mitchell SN, Gray JA (1996) Modulation of dopamine release in the nucleus accumbens by 5-HT1B agonists: involvement of the hippocampo-accumbens pathway. Neuropharmacology 35:1521–1529PubMedGoogle Scholar
  4. Bozarth MA (1987) Neuroanatomical boundaries of the reward relevant opiate receptors field in the ventral tegmental area as mapped by the conditioned place preference method in rats. Brain Res 414:77–84PubMedGoogle Scholar
  5. Brebner K, Phelan R, Roberts DC (2000) Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology 148:314–321Google Scholar
  6. Bruinvels AT, Landwehrmeyer B, Gustafson EL, Durkin MM, Mengod G, Branchek TA, Hoyer D, Palacios JM (1994) Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology 33:367–386PubMedGoogle Scholar
  7. Callahan PM, Cunningham KA (1995) Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors. J Pharmacol Exp Ther 274:1414–1424PubMedGoogle Scholar
  8. Callahan PM, De La Garza R 2nd, Cunningham KA (1997) Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 57:601–607PubMedGoogle Scholar
  9. Cameron DL, Williams JT (1994) Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci 14:6763–6767PubMedGoogle Scholar
  10. Carelli RM, Ijames SG (2000) Nucleus accumbens cell-firing during maintenance, extinction and reinstatement of cocaine self-administration behavior in rats. Brain Res 866:44–54PubMedGoogle Scholar
  11. Carlezon WA, Wise RA (1996) Rewarding action of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16:3112–3122PubMedGoogle Scholar
  12. Castanon N, Scearce-Levie K, Lucas JJ, Rocha B, Hen R (2000) Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knock-outs and antagonists. Pharmacol Biochem Behav 67:559–566PubMedGoogle Scholar
  13. Cazala P, Darracq C, Saint Marc M (1987) Self-administration of morphine into the lateral hypothalamus in the mouse. Brain Res 416:283–288PubMedGoogle Scholar
  14. David V, Durkin TP, Cazala P (1998) Rewarding effects elicited by the microinjection of either AMPA or NMDA glutamatergic antagonists into the ventral tegmental area revealed by an intracranial self-administration paradigm in mice. Eur J Neurosci 10:1394–1402PubMedGoogle Scholar
  15. David V, Gold LH, Koob GF, Cazala P (2001) Anxiogenic-like effects limit rewarding effects of cocaine in BALB/cByJ mice. Neuropsychopharmacology 24:300–318CrossRefPubMedGoogle Scholar
  16. David V, Durkin TP, Cazala P (2002) Differential effect of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens. Psychopharmacology 160:307–317CrossRefPubMedGoogle Scholar
  17. De La Garza R 2nd, Callahan PM, Cunningham KA (1998) The discriminative stimulus properties of cocaine: effects of microinfusion of cocaine, a 5-HT1A agonist or antagonist, into the ventral tegmental area. Psychopharmacology 137:1–6CrossRefPubMedGoogle Scholar
  18. Ettenberg A, Geist TD (1991) Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology 103:455–461Google Scholar
  19. Filip M, Papla I, Nowak E, Czepiel K, Przegalinski E. (2003) Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on cocaine discrimination in rats. Eur J Pharmacol 459:239–245CrossRefPubMedGoogle Scholar
  20. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. San Diego, Academic PressGoogle Scholar
  21. Giros B, Jaber M, Jones SR Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996:379:606–612Google Scholar
  22. Glowa JR, Wojnicki FH (1996) Effects of drugs on food- and cocaine-maintained responding, III: Dopaminergic antagonists. Psychopharmacology 128:351–358Google Scholar
  23. Goeders NE, Smith JE (1983) Cortical dopaminergic involvement in cocaine reinforcement. Science 221:773–775PubMedGoogle Scholar
  24. Harris GC, Aston-Jones G (2003) Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment. Neuropsychopharmacology 28:73–76CrossRefPubMedGoogle Scholar
  25. Harrison AA, Parsons LH, Koob GF, Markou A (1999) RU24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR127935, a 5-HT1B/1D antagonist. Psychopharmacology 141:242–250PubMedGoogle Scholar
  26. Hubner CB, Koob GF (1990) The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat. Brain Res 508:20–29PubMedGoogle Scholar
  27. Ikemoto S (2003) Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies. J Neurosci 23:9305–9311PubMedGoogle Scholar
  28. Ikemoto S, Murphy JM, McBride MC (1998) Regional differences within the rat ventral tegmental area for muscimol self-infusions. Pharmacol Biochem Behav 61:87–92CrossRefPubMedGoogle Scholar
  29. Johnson SW, Mercuri NB, North RA (1992) 5-Hydroxytryptamine 1B receptors block the GABA B synaptic potential in rat dopamine neurons. J Neurosci 12:2000–2006PubMedGoogle Scholar
  30. Lucas JJ, Segu L, Hen R (1997) 5-Hydroxytryptamine 1B receptors modulate the effect of cocaine on c-fos expression: converging evidence using 5-hydroxytryptamine 1B knockout mice and the 5-hydroxytryptamine 1B/1D antagonist GR 127935. Mol Pharmacol 51:755–763PubMedGoogle Scholar
  31. Maldonado R, Robledo P, Chover AJ, Caine SB, Koob GF (1993) D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol Biochem Behav 45:239–242PubMedGoogle Scholar
  32. McGregor A, Baker G, Roberts DC (1996) Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 53:5–9Google Scholar
  33. Muramatsu M, Lapiz MD, Tanaka E, Grenhoff J (1998) Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors. Eur J Neurosci 10:2371–2379PubMedGoogle Scholar
  34. Neumaier JF, Vincow ES, Arvanitogiannis A, Wise RA, Carlezon WA Jr (2002) Elevated expression of 5-HT1B receptors in nucleus accumbens efferents sensitizes animals to cocaine. J Neurosci 22:10856–10863PubMedGoogle Scholar
  35. Parsons LH, Weiss F, Koob GF (1996) Serotonin 1B receptor stimulation enhances dopamine-mediated reinforcement. Psychopharmacology 128:150–160Google Scholar
  36. Parsons LH, Weiss F, Koob GF (1998) Serotonin 1B receptor stimulation enhances cocaine reinforcement. J Neurosci 18:10078–10089PubMedGoogle Scholar
  37. Pauwels PJ (1997) 5-HT1B/1D receptor antagonists. Gen Pharmacol 29:293–303PubMedGoogle Scholar
  38. Phillips AG, Le Piane FG (1980) Reinforcing effects of morphine micro-injection into the ventral tegmental area. Pharmacol Biochem Behav 12:965–968PubMedGoogle Scholar
  39. Przegalinski E, Filip M, Papla I, Siwanowicz J (2001) Effect of serotonin (5-HT)1B receptor ligands on cocaine sensitization in rats. Behav Pharmacol 12:109–116PubMedGoogle Scholar
  40. Ranaldi R, Wise RA (2001) Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J Neurosci 21:5841–5846PubMedGoogle Scholar
  41. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219–1223PubMedGoogle Scholar
  42. Roberts DC, Koob GF (1982) Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav 17:901–904Google Scholar
  43. Robledo P, Koob GF (1993) Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav Brain Res 55:159–166PubMedGoogle Scholar
  44. Robledo P, Maldonado-Lopez R, Koob GF (1992) Role of dopamine receptors in the nucleus accumbens in the rewarding properties of cocaine. Ann N Y Acad Sci 654:509–512PubMedGoogle Scholar
  45. Rocha A, Ator R, Emmett-Oglesby MW, Hen R (1997) Intravenous cocaine self-administration in mice lacking 5-HT1B receptors. Pharmacol Biochem Behav 57:407–412PubMedGoogle Scholar
  46. Rocha, BA Fumagalli F, Gainetdinov RR, Jones SR, Atos R, Giros B et al. (1998a) Cocaine self-administration in dopamine- transporter knockout mice. Nat Neurosci 1:132–137PubMedGoogle Scholar
  47. Rocha BA, Scearce-Levie K, Lucas JJ, Hiroi N, Castanon N, Crabbe JC, Nestler EJ, Hen R (1998b) Increased vulnerability to cocaine in mice lacking the serotonin 1B receptor. Nature 393:175–178PubMedGoogle Scholar
  48. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R et al. (1998) Cocaine reward models: conditioned place preference can be established in dopamine and serotonin-transporter knockout mice. Proc Natl Acad Sci USA 95:7699–7704PubMedGoogle Scholar
  49. Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB et al. (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine preference. Proc Natl Acad Sci USA 98:5300–5305PubMedGoogle Scholar
  50. Tanaka E, North RA (1993) Cocaine enhancement of the action of 5-hydroxytryptamine in rat cingulate cortex in vitro. Neurosci Lett 163:50–52PubMedGoogle Scholar
  51. Uhl GR, Hall FS, Sora I (2002) Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7:21–26CrossRefPubMedGoogle Scholar
  52. Uzwiak AJ, Guyette FX, West MO, Peoples LL (1997) Neurons in accumbens subterritories of the rat: phasic firing time-locked within seconds of intravenous cocaine self-infusion. Brain Res 767:363–369CrossRefPubMedGoogle Scholar
  53. Van Bockstaele EJ, Cestari DM, Pickel VM (1994) Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons. Brain Res 647:307–322PubMedGoogle Scholar
  54. Yan QS, Yan SE (2001) Serotonin-1B receptor-mediated inhibition of 3H-GABA release from rat ventral tegmental area slices. J. Neurochem 79:914–922CrossRefGoogle Scholar
  55. Zangen A, Ikemoto S, Zadina JE, Wise RA (2002) Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. J Neurosci 22:7225–7233PubMedGoogle Scholar
  56. Zito KA, Vickers G, Roberts DC (1985) Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol Biochem Behav. 23:1029–1036Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Vincent David
    • 1
  • Louis Segu
    • 1
  • Marie-Christine Buhot
    • 1
  • Marina Ichaye
    • 1
  • Pierre Cazala
    • 1
  1. 1.Laboratoire de Neurosciences Cognitives, CNRS UMR 5106Université de Bordeaux ITalence CedexFrance

Personalised recommendations